NEWLUX 100 is a cutting-edge botulinum toxin developed by the Korean company Medytox and its subsidiary Newmeco. Approved in August by the Minister of Food and Drug Safety, NEWLUX sets itself apart by excluding animal-derived ingredients in its production, thereby reducing the risk of allergic reactions caused by animal antigens.